LINCOLN, Neb. (April 15, 2024) – LICORbio, formerly LI-COR Biotechnology, a global pioneer in life science instrumentation, recently launched a pair of brand-new Odyssey® F biomolecular imaging systems. Both models will provide researchers with significantly faster scans, greater value and expanded assay support, as well as the unparalleled dynamic range and data confidence they have come to expect from LICORbio.
“The Odyssey F represents the next generation of LICORbio’s foundational Odyssey product family,” said Mike Furtaw, director of research and development at LICORbio. “These industry-leading optical imaging systems will address our customers’ need for greater imaging speed, application versatility and multiplexing capabilities in both the visible and NIR range.”
For decades, LICORbio has pioneered the development of groundbreaking near-infrared (NIR) biological instrumentation. Their imagers have been proven to achieve the highest data fidelity, with more than 40,000 articles in peer-reviewed publications citing their use. Some of the most well-known names in science have published using LICORbio products, including several prestigious research institutions and major pharmaceutical companies.
LICORbio’s new Odyssey F imagers will be available in two distinct models featuring either three or 10 available channels. Both models can complete scans twice as fast as the current industry-leading point scanner, and significantly faster than competitive laser-based instruments.
The three-channel, dual-NIR-laser Odyssey F provides greater throughput and higher performance than other imagers, and the best opportunity for quantitative imaging. With the addition of two visible fluorescence lasers, the 10-channel Odyssey F adds powerful multiplexing capabilities for plate-based assays, slide imaging and more.
“Our goal is to provide our customers with greater flexibility in choosing the right solution for their lab’s unique needs,” said Katie Schaepe, director of marketing at LICORbio. “The Odyssey F imagers will enable more researchers to explore new opportunities while also ensuring confidence, reliability and data integrity. LICORbio is committed to improving the human condition by supporting scientists every step of the way, and the Odyssey F embodies that commitment.”
Learn more about LICORbio and the Odyssey F Imaging Systems at licor.com/bio.
About LI-COR:
LICORbio, a brand of LI-COR Biosciences, develops state-of-the-art imaging solutions integrated with dedicated reagents, powerful software and unmatched support to help scientists obtain reliable, quantitative research results. With over 40,000 citations in peer-reviewed publications, these solutions help to improve lives by advancing discovery with speed, accuracy and consistency. LICORbio continually strives to improve the human condition through innovative research tools that enable scientists solve the challenges that face humanity. More information at licor.com/bio. LI-COR Biosciences is ISO 9001:2015 certified.
For more information, please contact:
Lynette Von Minden, Swanson Russell lynettev@swansonrussell.com 402-437-6457
Katie Schaepe, LI-CORbio Katie.schaepe@licor.com 402-467-0700